Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression

Yu Hu Chiou, Saou Hsing Liou, Ruey Hong Wong, Chih Yi Chen, Huei Lee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We recently reported that nickel accumulation in lung tissues may be associated with an increased in p53 mutation risk via reduced DNA repair activity. Here, we hypothesized that nickel accumulation in lung tissues could contribute to EGFR mutations in never-smokers with lung cancer. We enrolled 76 never-smoking patients to evaluate nickel level in adjacent normal lung tissues by ICP-MS. The prevalence of EGFR mutations was significantly higher in the high-nickel subgroup than in the low-nickel subgroup. Intriguingly, the OR for the occurrence of EGFR mutations in female, adenocarcinoma, and female adenocarcinoma patients was higher than that of all patients. Mechanistically, SPRY2 and RECK expressions were decreased by nickel-induced miR-21 via activation of the EGFR/NF-κB signaling pathway, which promoted invasiveness in lung cancer cells, and particularly in the cells with EGFR L858R expression vector transfection. The patients' nickel levels were associated with miR-21 expression levels. Kaplan-Meier analysis revealed poorer overall survival (OS) and shorter relapse free survival (RFS) in the high-nickel subgroup than in low-nickel subgroup. The high-nickel/high-miR-21 subgroup had shorter OS and RFS periods when compared to the low-nickel/low-miR-21 subgroup. Our findings support previous epidemiological studies indicating that nickel exposure may not only contribute to cancer incidence but also promote tumor invasion in lung cancer.

Original languageEnglish
Pages (from-to)46-54
Number of pages9
JournalToxicology Letters
Volume237
Issue number1
DOIs
Publication statusPublished - Aug 9 2015

Fingerprint

Nickel
MicroRNAs
Tumors
Lung Neoplasms
Mutation
Neoplasms
Survival
Tissue
Lung
Adenocarcinoma
Recurrence
Kaplan-Meier Estimate
DNA Repair
Transfection
Epidemiologic Studies
Repair
Smoking
Chemical activation
Cells

Keywords

  • EGFR mutation
  • MiR-21
  • Nickel
  • NSCLC
  • RECK

ASJC Scopus subject areas

  • Toxicology

Cite this

Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression. / Chiou, Yu Hu; Liou, Saou Hsing; Wong, Ruey Hong; Chen, Chih Yi; Lee, Huei.

In: Toxicology Letters, Vol. 237, No. 1, 09.08.2015, p. 46-54.

Research output: Contribution to journalArticle

Chiou, Yu Hu ; Liou, Saou Hsing ; Wong, Ruey Hong ; Chen, Chih Yi ; Lee, Huei. / Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression. In: Toxicology Letters. 2015 ; Vol. 237, No. 1. pp. 46-54.
@article{93f113ea0d71495f9af4733d7a6c3b7b,
title = "Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression",
abstract = "We recently reported that nickel accumulation in lung tissues may be associated with an increased in p53 mutation risk via reduced DNA repair activity. Here, we hypothesized that nickel accumulation in lung tissues could contribute to EGFR mutations in never-smokers with lung cancer. We enrolled 76 never-smoking patients to evaluate nickel level in adjacent normal lung tissues by ICP-MS. The prevalence of EGFR mutations was significantly higher in the high-nickel subgroup than in the low-nickel subgroup. Intriguingly, the OR for the occurrence of EGFR mutations in female, adenocarcinoma, and female adenocarcinoma patients was higher than that of all patients. Mechanistically, SPRY2 and RECK expressions were decreased by nickel-induced miR-21 via activation of the EGFR/NF-κB signaling pathway, which promoted invasiveness in lung cancer cells, and particularly in the cells with EGFR L858R expression vector transfection. The patients' nickel levels were associated with miR-21 expression levels. Kaplan-Meier analysis revealed poorer overall survival (OS) and shorter relapse free survival (RFS) in the high-nickel subgroup than in low-nickel subgroup. The high-nickel/high-miR-21 subgroup had shorter OS and RFS periods when compared to the low-nickel/low-miR-21 subgroup. Our findings support previous epidemiological studies indicating that nickel exposure may not only contribute to cancer incidence but also promote tumor invasion in lung cancer.",
keywords = "EGFR mutation, MiR-21, Nickel, NSCLC, RECK",
author = "Chiou, {Yu Hu} and Liou, {Saou Hsing} and Wong, {Ruey Hong} and Chen, {Chih Yi} and Huei Lee",
year = "2015",
month = "8",
day = "9",
doi = "10.1016/j.toxlet.2015.05.019",
language = "English",
volume = "237",
pages = "46--54",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression

AU - Chiou, Yu Hu

AU - Liou, Saou Hsing

AU - Wong, Ruey Hong

AU - Chen, Chih Yi

AU - Lee, Huei

PY - 2015/8/9

Y1 - 2015/8/9

N2 - We recently reported that nickel accumulation in lung tissues may be associated with an increased in p53 mutation risk via reduced DNA repair activity. Here, we hypothesized that nickel accumulation in lung tissues could contribute to EGFR mutations in never-smokers with lung cancer. We enrolled 76 never-smoking patients to evaluate nickel level in adjacent normal lung tissues by ICP-MS. The prevalence of EGFR mutations was significantly higher in the high-nickel subgroup than in the low-nickel subgroup. Intriguingly, the OR for the occurrence of EGFR mutations in female, adenocarcinoma, and female adenocarcinoma patients was higher than that of all patients. Mechanistically, SPRY2 and RECK expressions were decreased by nickel-induced miR-21 via activation of the EGFR/NF-κB signaling pathway, which promoted invasiveness in lung cancer cells, and particularly in the cells with EGFR L858R expression vector transfection. The patients' nickel levels were associated with miR-21 expression levels. Kaplan-Meier analysis revealed poorer overall survival (OS) and shorter relapse free survival (RFS) in the high-nickel subgroup than in low-nickel subgroup. The high-nickel/high-miR-21 subgroup had shorter OS and RFS periods when compared to the low-nickel/low-miR-21 subgroup. Our findings support previous epidemiological studies indicating that nickel exposure may not only contribute to cancer incidence but also promote tumor invasion in lung cancer.

AB - We recently reported that nickel accumulation in lung tissues may be associated with an increased in p53 mutation risk via reduced DNA repair activity. Here, we hypothesized that nickel accumulation in lung tissues could contribute to EGFR mutations in never-smokers with lung cancer. We enrolled 76 never-smoking patients to evaluate nickel level in adjacent normal lung tissues by ICP-MS. The prevalence of EGFR mutations was significantly higher in the high-nickel subgroup than in the low-nickel subgroup. Intriguingly, the OR for the occurrence of EGFR mutations in female, adenocarcinoma, and female adenocarcinoma patients was higher than that of all patients. Mechanistically, SPRY2 and RECK expressions were decreased by nickel-induced miR-21 via activation of the EGFR/NF-κB signaling pathway, which promoted invasiveness in lung cancer cells, and particularly in the cells with EGFR L858R expression vector transfection. The patients' nickel levels were associated with miR-21 expression levels. Kaplan-Meier analysis revealed poorer overall survival (OS) and shorter relapse free survival (RFS) in the high-nickel subgroup than in low-nickel subgroup. The high-nickel/high-miR-21 subgroup had shorter OS and RFS periods when compared to the low-nickel/low-miR-21 subgroup. Our findings support previous epidemiological studies indicating that nickel exposure may not only contribute to cancer incidence but also promote tumor invasion in lung cancer.

KW - EGFR mutation

KW - MiR-21

KW - Nickel

KW - NSCLC

KW - RECK

UR - http://www.scopus.com/inward/record.url?scp=84930641697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930641697&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2015.05.019

DO - 10.1016/j.toxlet.2015.05.019

M3 - Article

C2 - 26026961

AN - SCOPUS:84930641697

VL - 237

SP - 46

EP - 54

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 1

ER -